Published on
Jan 29, 2025
Amid more drug-price scrutiny, biopharma companies largely keep their January hikes in check
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down their urge to jack them up, settling for more modest, across-the-board increases. More than 930 drug products have seen list price …
Source:
Fierce Pharma
-
Neutral
